Page 767 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 767

CHaPTEr 54  Sjögren Syndrome               739


           involvement is dry, itchy skin (xerosis) and angular cheilitis.
           Other less common nonvasculitic lesions include alopecia, vitiligo,   Genitourinary and Renal Involvement
           eyelid dermatitis, and erythema nodosum–like lesions. Annular   Renal involvement is frequently caused by tubulointerstitial
           erythema, a rash similar to subacute cutaneous lupus, has been   nephritis often presenting as distal (type1) renal tubular acidosis,
           reported in about 10% of patients with SS and is closely associated   renal  calculi,  and  hypokalemia.  Glomerular  disease  has  been
           with the presence of anti-SSA and/or anti-SSB autoantibod-  rarely reported and, in most cases, is linked to cryoglobulinemic
           ies. However, the rash is less photosensitive and histologically   vasculitis. Inflammation of the urinary bladder epithelium can
           has deeper perivascular and periappendageal lymphocytic    cause interstitial cystitis. Vaginal dryness leading to dyspareunia
           infiltrates.                                           has been reported in 40% of women.
             Vasculitic lesions include nonpalpable purpura caused by
           hypergammaglobulinemia, palpable purpura, and urticarial vas-  Clinical Manifestations in Children
                19
           culitis.  Patients with vasculitis have higher prevalence of positive   Primary SS is rarely diagnosed in children, but many adult patients
           ANA, anti-Ro/SSA antibodies, and rheumatoid factor compared   with SS recall the presence of symptoms since childhood. Clinical
           with those with nonvasculitic skin involvement. Palpable purpura   presentation in children is more insidious with predominant
           is histologically characterized by leukocytoclastic vasculitis and   recurrent parotitis and, less commonly, sicca symptoms. 26
           may indicate presence of underlying cryoglobulinemia. Raynaud
           phenomenon (RP) is seen in 30–50% of SS patients and frequently   Associated Autoimmune Conditions
           precedes the development of sicca symptoms.            Autoimmune thyroiditis is seen in more than one-third of patients
                                                                  with SS. Celiac disease is also increasingly recognized in these
           Gastrointestinal Involvement                           patients, with a prevalence 10 times higher than in the general
           Dysphagia is common as a result of dryness of the pharynx and   population.
           esophageal dysmotility. Nausea, epigastric pain, and constipation
           are frequently encountered. Gastrointestinal (GI) tract dysmotility   Lymphoma Associated With SS
           can be seen as a result of ANS involvement. Pancreatic dysfunction,   SS is associated with increased risk of lymphoma, with about
           with reduced production of amylase and lipase, is present in   5% of patients developing lymphoma. In a meta-analysis of 20
           25% of patients with SS.                               studies the standardized incidence rate of lymphoma was 18.9%
                                                                                             27
                                                                  (confidence interval [CI] 9.4–37.9).  Most of these are low-grade
           Pulmonary Involvement                                  marginal zone lymphomas of the mucosa-associated lympho-
           Cough is a common complaint in patients with SS and results   reticular tissue (MALT) type. Only 10% of lymphomas in patients
           from tracheobronchitis sicca (tracheal and bronchial dryness).   with SS evolve into a less differentiated cell (more aggressive)
           Clinically significant pulmonary involvement is reported in   variety. Risk factors for development of lymphoma include
                              20
           9–12% of SS patients.  Pulmonary manifestations include   persistent enlargement of the parotid glands, palpable purpura,
           large airway disease and small airway disease, bronchial hyper-  leg ulcers secondary to vasculitis, mixed cryoglobulinemia, and
           responsiveness, recurrent respiratory infections, interstitial lung   low C4 levels.
           disease, pulmonary hypertension, pleuritis, and pulmonary
           amyloidosis. Interstitial lung disease is increasingly recognized   DIAGNOSIS AND CLASSIFICATION CRITERIA
           as an extraglandular manifestation of SS and can precede the
           diagnosis of SS.                                       Patients with SS can present with heterogeneous combinations
             Patients with primary SS presenting with unexplained dyspnea   of sicca symptoms and extraglandular manifestations. Moreover,
           should be evaluated for pulmonary arterial hypertension (PAH);   various clinical syndromes and medications can lead to similar
           an unexpectedly high prevalence (14%) of pulmonary hyperten-  symptoms and mimic SS. The diagnosis of SS is based on the
           sion was found in a cohort of 1158 patients. The majority of   combination of subjective symptoms of dryness (sicca symptoms),
           patients with SS and PAH manifest symptoms early in the disease   objective evidence of lachrymal or salivary gland hypofunction,
           course. 21,22                                          and evidence of autoimmunity or salivary gland inflammation.
                                                                  Classification criteria were proposed by an American–European
           Cardiac Involvement                                    consensus group (AECG) in 2002,  primarily for classification
                                                                                             28
           Clinically significant cardiac involvement is uncommon in primary   of patients in clinical studies. These criteria are widely accepted
           SS. Patients may develop pericarditis, thickened pericardium,   and are frequently used as a guide for clinical diagnosis. Applica-
           or left ventricle diastolic dysfunction. Rhythm abnormalities   tion of these criteria to classify patients with primary SS has a
           resulting from autonomic dysfunction may be encountered.   sensitivity of 89.5% and specificity of 95.2%, whereas for second-
                                                                                                                   28
           Placental transfer of anti-SSA/Ro and anti-SSB/La antibodies   ary SS, it has a sensitivity of 97.2% and specificity of 90.2%.
           from pregnant patients with SS can cause lesions in the cardiac   The AECG classification scheme is based on a set of two subjective
           conducting system of the fetus. Pregnant women with positive   criteria and four objective criteria.
           anti-SSA/Ro and anti-SSB/La antibodies have a 2.5% risk of   Patients are classified as having primary SS in the absence of
           delivering a baby with congenital heart block.         any other systemic autoimmune disease, whereas in secondary
             Like patients with other chronic inflammatory conditions,   SS, sicca manifestations are present in conjunction with other
           patients with SS are at an increased risk of premature atheroscle-  underlying autoimmune diseases, such as SLE, RA, polymyositis/
           rosis and cardiovascular events. Some traditional cardiovascular   dermatomyositis, or systemic sclerosis. SS is excluded if patients
           risk factors, such as hypertension and hypercholesterolemia, are   use anticholinergic medications or have other conditions that
           more prevalent in patients with SS. However, disease-specific   can mimic SS, such as chronic viral infections, graft-versus-host
           factors  also  contribute  to  the  pathogenesis  of  premature    disease (GvHD), or status post irradiation of the head and neck
           atherosclerosis. 23-25                                 region.
   762   763   764   765   766   767   768   769   770   771   772